
| 4 min read
Data on a new oral pill for Duchenne muscular dystrophy, a miss for a heart drug, a $10B acquisition of Crinetics, and more led the news this week.
| 4 min read
7-methylxanthine is being reformulated into a sustained-release oral therapy aimed at improving long-term control of axial elongation in childhood myopia.
| 5 min read
The Synthetic Molecule Process Innovation Phorum brings together major pharma companies, regulators, and CDMOs to build consensus on pressing challenges in small molecule manufacturing. News
Cancer Research News
Researchers are uncovering new ways to attack some of cancer’s most elusive drivers.
By stabilizing G-quadruplex DNA, a revived anticancer drug offers a new way to shut down a key oncogene.
Editor's Pick
Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.
In a journey fraught with heartache and persistence, medical research giants paved the way for successful bone marrow transplantation.
Multimedia
Learn the key characteristics that determine whether an immunoassay generates accurate and reproducible data.
Discover why mass photometry is becoming essential in the toolbox of protein studies.






















